×
For best experience we recommend to activate Javascript in your browser.
CD235a/GYPA antibody (AA 20-91)
The Rabbit Polyclonal anti-CD235a/GYPA antibody has been validated for IHC, WB, IP and ICC. It is suitable to detect CD235a/GYPA in samples from Human.
Quick Overview for CD235a/GYPA antibody (AA 20-91) (ABIN7618413)
Target
See all CD235a/GYPA (GYPA) Antibodies
CD235a/GYPA (GYPA)
(Glycophorin A (GYPA))
Reactivity
All reactivities for CD235a/GYPA antibodies
Human
Host
All hosts for CD235a/GYPA antibodies
Rabbit
Clonality
All clonalities for CD235a/GYPA antibodies
Polyclonal
Conjugate
All conjugates for CD235a/GYPA antibodies
This CD235a/GYPA antibody is un-conjugated
Application
All applications for CD235a/GYPA antibodies
Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CD235a/GYPA Antibody
(hide)
Binding Specificity
All epitopes for CD235a/GYPA antibodies
AA 20-91
Purpose
Glycophorin A (GYPA) Polyclonal Antibody
Sequence
Leu20~Glu91
Characteristics
The Glycophorin A (GYPA) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CD235a/GYPA
(hide)
Target
CD235a/GYPA (GYPA)
(Glycophorin A (GYPA))
Alternative Name
GYPA
Gene ID
2993
UniProt
P02724
Pathways
Maintenance of Protein Location
Recently viewed
(hide)
Chat with us , powered by LiveChat